Lexington, MA, United States of America

Pulmatrix Operating Company, Inc.

Calculating rank
USPTO Granted Patents = 9



Forward Citations = 27

Loading Chart...
Loading Chart...

13 inventors (with patents filed for the assignee):

goldMedal Jean C Sung (9 out of 18 patents)

silverMedal Michael M Lipp (5 out of 31 patents)

bronzeMedal Diana Manzanedo (3 out of 4 patents)

4.  Wesley H DeHaan (2 out of 4 patents)

5.  Ciaran Lawlor (2 out of 3 patents)

6.  Michael Tauber (2 out of 5 patents)

7.  Jason M Perry (2 out of 22 patents)

8.  David L Hava (1 out of 2 patents)

9.  Robert Clifford Saunders (1 out of 1 patent)

10.  Hillary S Bergson (1 out of 1 patent)

11.  Andrew Emmet O'Connor (1 out of 1 patent)

12.  Brian Trautman (1 out of 1 patent)

13.  Wesley Dehaan (1 out of 1 patent)

14.  Robert William Clarke (6 patents)

15.  Wesley H Dehaan (0 patent)


9 patents:

Company Overview
Pulmatrix Operating Company, Inc. is a clinical stage biotechnology company developing innovative inhaled therapies to address serious pulmonary diseases. The company's proprietary technology platform enables the delivery of a wide range of drugs directly to the lungs, maximizing therapeutic impact while minimizing systemic side effects. Pulmatrix focuses on improving the lives of patients with respiratory conditions through its novel pulmonary drug delivery technology.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

9 Patents

#68 in Lexington, MA

#1,927 in Massachusetts

#32,649 in US

Lexington, MA (US)
Lexington, MA, United States of America
Forward Citations = 27

13 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Pulmatrix Operating Company, Inc.. Retrieved from https://idiyas.com/company/pulmatrix-operating-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…